A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT05250115 · clinicaltrials.gov ↗
TERMINATED
Status
112
Enrollment
INDUSTRY
Sponsor class

Stopped Business decision: Due to the slow recruitment, the sponsor decided to discontinue the study early.

Conditions

Sponsor

Pfizer